BRPI0908584A2 - agente para prevenir e/ou tratar doenças vasculares - Google Patents

agente para prevenir e/ou tratar doenças vasculares

Info

Publication number
BRPI0908584A2
BRPI0908584A2 BRPI0908584A BRPI0908584A BRPI0908584A2 BR PI0908584 A2 BRPI0908584 A2 BR PI0908584A2 BR PI0908584 A BRPI0908584 A BR PI0908584A BR PI0908584 A BRPI0908584 A BR PI0908584A BR PI0908584 A2 BRPI0908584 A2 BR PI0908584A2
Authority
BR
Brazil
Prior art keywords
agent
prevent
vascular diseases
treat vascular
treat
Prior art date
Application number
BRPI0908584A
Other languages
English (en)
Inventor
Chinatsu Sakurai
Tomihisa Kawasaki
Toshiyuki Funatsu
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0908584A2 publication Critical patent/BRPI0908584A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
BRPI0908584A 2008-04-01 2009-03-31 agente para prevenir e/ou tratar doenças vasculares BRPI0908584A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008095370 2008-04-01
PCT/JP2009/056708 WO2009123210A1 (ja) 2008-04-01 2009-03-31 血管性疾患の予防剤及び／又は治療剤

Publications (1)

Publication Number Publication Date
BRPI0908584A2 true BRPI0908584A2 (pt) 2015-09-15

Family

ID=41135578

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908584A BRPI0908584A2 (pt) 2008-04-01 2009-03-31 agente para prevenir e/ou tratar doenças vasculares

Country Status (13)

Country Link
US (1) US20110034504A1 (pt)
EP (1) EP2258364A4 (pt)
JP (1) JP5589838B2 (pt)
KR (1) KR20100137448A (pt)
CN (1) CN101983056A (pt)
AU (1) AU2009232710A1 (pt)
BR (1) BRPI0908584A2 (pt)
CA (1) CA2720278A1 (pt)
IL (1) IL208231A0 (pt)
MX (1) MX2010010869A (pt)
RU (1) RU2010144554A (pt)
WO (1) WO2009123210A1 (pt)
ZA (1) ZA201006660B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012170839A2 (en) * 2011-06-09 2012-12-13 Cardeus Pharmaceuticals, Inc. Treatment of neuroinflammatory disease with selective cox1 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
AUPR878201A0 (en) * 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds
CA2611741A1 (en) * 2005-06-13 2006-12-28 Elan Pharma International, Limited Nanoparticulate clopidogrel and aspirin combination formulations
US20080213383A1 (en) * 2005-09-06 2008-09-04 Astellas Pharma Inc. Fine particles of poorly water-soluble drug having enteric material adsorbed on particle surface
JPWO2007091719A1 (ja) * 2006-02-07 2009-07-02 持田製薬株式会社 抗ｇｐｖｉ抗体の併用療法及び新規医薬用途
WO2008029912A1 (fr) * 2006-09-07 2008-03-13 National University Corporation Okayama University Composé ayant un squelette de benzamide et une activité inhibitrice sélective de la cyclo-oxygénase (cox-1)

Also Published As

Publication number Publication date
IL208231A0 (en) 2010-12-30
JP5589838B2 (ja) 2014-09-17
WO2009123210A1 (ja) 2009-10-08
KR20100137448A (ko) 2010-12-30
US20110034504A1 (en) 2011-02-10
AU2009232710A1 (en) 2009-10-08
EP2258364A4 (en) 2012-07-25
JPWO2009123210A1 (ja) 2011-07-28
ZA201006660B (en) 2011-12-28
CN101983056A (zh) 2011-03-02
MX2010010869A (es) 2010-11-12
RU2010144554A (ru) 2012-05-10
CA2720278A1 (en) 2009-10-08
EP2258364A1 (en) 2010-12-08

Similar Documents

Publication Publication Date Title
BRPI0819361A2 (pt) Composição de tratamento de cabelos e agente de tratamento
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0915112A2 (pt) cateter de entalhe para tratar válvulas cardíacas doentes
BRPI0921237A2 (pt) métodos e composições para o tratamento de distúrbios associados ao complemento
BRPI0920030A2 (pt) agente de oclusão do tecido
BRPI0910874A8 (pt) composições e métodos para cuidado da pele
BRPI0917378A2 (pt) tratamento da transpiracao e da hiperidrose
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BR112014009634A2 (pt) preparação e agente terapêutico
BRPI0907918A2 (pt) Ácidos sulfoperoxicarxílicos, sua preparação e métodos de utilizção como agentes alvejantes e antimicrobianos
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
BRPI0821220A2 (pt) Composiçoes e métodos para reduzir ou prevenir perda de água da pele
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI1010517A2 (pt) métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
BRPI1014922A2 (pt) métodos e composições para tratar doenças de pele associadas com hiper-reatividade vascular
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BRPI1014390A2 (pt) composto de sal de amônio quaternário, composição medicinal, e, agente preventivo ou terapêutico
BRPI0916043A2 (pt) composição farmacêutica e alimento funcional para prevenir ou tratar câncer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.